These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 16412031

  • 1. Pathogenesis of nonalcoholic steatohepatitis (NASH).
    Ma X, Li Z.
    Chin J Dig Dis; 2006; 7(1):7-11. PubMed ID: 16412031
    [Abstract] [Full Text] [Related]

  • 2. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.
    Carter-Kent C, Zein NN, Feldstein AE.
    Am J Gastroenterol; 2008 Apr; 103(4):1036-42. PubMed ID: 18177455
    [Abstract] [Full Text] [Related]

  • 3. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH.
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [Abstract] [Full Text] [Related]

  • 4. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery.
    Verna EC, Berk PD.
    Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297
    [Abstract] [Full Text] [Related]

  • 5. Nonalcoholic fatty liver disease/nonalcoholic steatohepatitis: histological diagnostic criteria and scoring systems.
    Tiniakos DG.
    Eur J Gastroenterol Hepatol; 2010 Jun; 22(6):643-50. PubMed ID: 19478676
    [Abstract] [Full Text] [Related]

  • 6. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [Abstract] [Full Text] [Related]

  • 7. Nonalcoholic steatohepatitis.
    Brunt EM.
    Semin Liver Dis; 2004 Feb; 24(1):3-20. PubMed ID: 15085483
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of disease progression in nonalcoholic fatty liver disease.
    Jou J, Choi SS, Diehl AM.
    Semin Liver Dis; 2008 Nov; 28(4):370-9. PubMed ID: 18956293
    [Abstract] [Full Text] [Related]

  • 9. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities.
    Gambino R, Musso G, Cassader M.
    Antioxid Redox Signal; 2011 Sep 01; 15(5):1325-65. PubMed ID: 20969475
    [Abstract] [Full Text] [Related]

  • 10. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition.
    Cave M, Deaciuc I, Mendez C, Song Z, Joshi-Barve S, Barve S, McClain C.
    J Nutr Biochem; 2007 Mar 01; 18(3):184-95. PubMed ID: 17296492
    [Abstract] [Full Text] [Related]

  • 11. Metabolic disturbances in non-alcoholic fatty liver disease.
    Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH.
    Clin Sci (Lond); 2009 Apr 01; 116(7):539-64. PubMed ID: 19243311
    [Abstract] [Full Text] [Related]

  • 12. Nonalcoholic fatty liver disease.
    Yu AS, Keeffe EB.
    Rev Gastroenterol Disord; 2002 Apr 01; 2(1):11-9. PubMed ID: 12122975
    [Abstract] [Full Text] [Related]

  • 13. Nonalcoholic fatty liver disease: pathogenesis and potential for nuclear receptors as therapeutic targets.
    George J, Liddle C.
    Mol Pharm; 2008 Apr 01; 5(1):49-59. PubMed ID: 18072723
    [Abstract] [Full Text] [Related]

  • 14. Nonalcoholic fatty liver disease as a complication of insulin resistance.
    Abdelmalek MF, Diehl AM.
    Med Clin North Am; 2007 Nov 01; 91(6):1125-49, ix. PubMed ID: 17964913
    [Abstract] [Full Text] [Related]

  • 15. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM.
    Aliment Pharmacol Ther; 2008 Jul 01; 28(1):2-12. PubMed ID: 18410557
    [Abstract] [Full Text] [Related]

  • 16. Fatty liver: role of inflammation and fatty acid nutrition.
    Byrne CD.
    Prostaglandins Leukot Essent Fatty Acids; 2010 Jul 01; 82(4-6):265-71. PubMed ID: 20189787
    [Abstract] [Full Text] [Related]

  • 17. Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease.
    Choudhury J, Sanyal AJ.
    Clin Liver Dis; 2004 Aug 01; 8(3):575-94, ix. PubMed ID: 15331065
    [Abstract] [Full Text] [Related]

  • 18. Evaluation and management of obesity-related nonalcoholic fatty liver disease.
    Nugent C, Younossi ZM.
    Nat Clin Pract Gastroenterol Hepatol; 2007 Aug 01; 4(8):432-41. PubMed ID: 17667992
    [Abstract] [Full Text] [Related]

  • 19. Nonalcoholic steatohepatitis and the metabolic syndrome.
    Jiang J, Torok N.
    Metab Syndr Relat Disord; 2008 Mar 01; 6(1):1-7. PubMed ID: 18370830
    [Abstract] [Full Text] [Related]

  • 20. Nonalcoholic steatohepatitis, animal models, and biomarkers: what is new?
    Ariz U, Mato JM, Lu SC, Martínez Chantar ML.
    Methods Mol Biol; 2010 Mar 01; 593():109-36. PubMed ID: 19957147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.